ADC Therapeutics
NYSE:ADCT
$ 3,97
+ $0,03 (0,76%)
3,97 $
+$0,03 (0,76%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,00
Earnings Per Share
$0,64
Revenue Per Share
92,87%
Gross Margin %
$0,50 B
Market Cap
$0,44 B
Long-Term Debt
Earnings Per Share
$0,00
Revenue Per Share
$0,64
Gross Margin %
92,87%
Market Cap
$0,50 B
Long-Term Debt
$0,44 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019
EPS Earnings Per Share $-1,12 $-1,62 $-2,94 $-1,99 $-3,00 $-3,77 $-2,36
Earnings Earnings $-142,28M $-160,51M $-242,64M $-160,47M $-230,43M $-289,23M $-121,54M
RPS Revenue Per Share $0,00 $0,64 $0,71 $0,84 $2,60 $0,44 $0,00 $0,05
Revenue Revenue $0,00M $81,36M $70,84M $69,56M $209,91M $33,92M $0,00M $2,34M
OCF Operating Cash Flow $0,00M $-156,59M $-123,84M $-118,69M $-136,79M $-233,38M $-168,73M $0,00M
FCF Free Cash Flow $0,00M $-140,00M $-124,70M $43,00M $-137,37M $-236,81M $0,00M $0,00M
OM Operating Margin 0,00% -133,21% -184,44% -238,63% -58,79% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 92,87% -63,17% -86,40% 16,72% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $0,00 $-1,28 $-1,49 $-1,78 $-3,12 $-2,62 $-2,51
LT Debt Long-Term Debt N/A $434,98M $433,73M $416,30M $322,07M $305,82M $34,78M N/A
Sha. Stocks 150,3M 127,04M 99,08M 82,53M 80,64M 76,81M 76,72M 51,5M
×